TOP STORIES

• ORGANIZATION RAD-AR Council Accelerating Initiative to Prepare Medication Guides in English toward Tokyo 2020 Olympic and Paralympic Games
  February 6, 2020

• ORGANIZATION Japan Red Cross Set to Push Formularies at All Group Hospitals, Despite Medical Fee Plan Dropped
  February 5, 2020

• BUSINESS Oncolys Hopes for Chugai’s Participation in US Development of Telomelysin: Chief
  February 4, 2020

• BUSINESS Opdivo Sales Drop 4.7% in April-December, but Ono Secures Higher Profits
  February 3, 2020

• BUSINESS Chugai Ups Core EPS CAGR Target to “Around 30%”: 3-Year Biz Plan
  January 31, 2020

• BUSINESS Chugai’s 2019 Earnings Renews Record for Third Year on Hemlibra, Tecentriq
  January 31, 2020

• REGULATORY Takeda’s RCC Drug Cabometyx Now in Line for March Approval; Alecensa, Rozlytrek Opdivo and More
  January 30, 2020

• REGULATORY Japan Ups Responses against Wuhan Coronavirus as First Domestic Transmission Confirmed
  January 29, 2020

• INTERVIEW “Excessive Self-Restraint” of Promotion Activities by Drug Makers Hindering Drugs’ Lifecycle Management: Physician
  January 28, 2020

• REGULATORY Discussions on Off-Year Re-Pricing to Begin in Spring, Focus on Scope of Drugs, Impact on Stakeholders: MHLW Bureau Chief
  January 27, 2020

• REGULATORY ICH’s Guidelines Helped Bring NDMA Contamination Problem to Light: NIHS Officials
  January 24, 2020

• REGULATORY Nasal Steroid Used as “Reference Drug” for Xolair in Special Re-Pricing
  January 23, 2020

• REGULATORY Get Serious about Reviewing Scope of Health Coverage, Says MOF Budget Examiner
  January 22, 2020

• REGULATORY Japan’s Special Re-Pricing Rules to Hit 17 Drugs in April; Potentially Big Slash for Keytruda, Lixiana
  January 22, 2020

• REGULATORY Xolair Faces New Special Re-Pricing Rule; Keytruda, Lixiana Caught by Huge-Seller Price Slash
  January 21, 2020

• BUSINESS Keytruda Snags Best-Seller Title in 2019 Drug Ranking: Encise
  January 20, 2020

• BUSINESS Xolair’s Use Would Be Limited to 1-3% of Pollen Allergy Patients in Japan: Specialist
  January 20, 2020

• REGULATORY MHLW Bureau Chief Says Delay Would Be Inevitable to Revise Drug Distribution Guidelines as Bid-Rigging Probe Continues
  January 17, 2020

• ACADEMIA Impact of Oligonucleotides - 1: Onpattro a Major Advance in FAP Treatment, but Challenges Remain
  January 16, 2020

• BUSINESS Tapped as Next Mitsubishi Tanabe Chief, Hiroaki Ueno Vows to Enrich Pipeline, Accelerate Global Biz
  January 15, 2020

ページ

• « 先頭
• ‹ Prev
• …
• 125
• 126
• 127
• 128
• 129
• 130
• 131
• 132
• 133
• …
• Next ›
• 最終 »